Table 1 Baseline clinical characteristics of subjects
| Â | Men | Women |
|---|---|---|
N | 2,323 | 2,104 |
Age (years) | 55.75 ± 11.63 | 56.50 ± 11.67 |
Duration of diabetes (years) | 6.67 ± 6.99 | 6.54 ± 6.20 |
SBP (mmHg) | 134.02 ± 17.03 | 136.84 ± 18.87 |
DBP (mmHg) | 87.86 ± 11.25 | 85.28 ± 11.32 |
Weight (kg) | 70.89 ± 10.20 | 59.34 ± 9.08 |
BMI (kg/m2) | 24.57 ± 3.25 | 24.56 ± 3.34 |
WC (cm) | 86.23 ± 7.74 | 79.41 ± 8.31 |
Smoking (n, %) | 354 (15.2%) | 32 (1.5%) |
Antihypertensive medication, N (%) | 720 (30.9) | 694 (32.9) |
Antidyslipidemic medication, N (%) | 464 (19.9) | 487 (23.1) |
Antidiabetic medication | Â | Â |
Sulfonylureas | 1441 (62.0) | 1328 (63.1) |
Metformin | 973 (41.8) | 1032 (49.0) |
AGIs | 246 (10.6) | 231 (10.9) |
FPG (mmol/L) | 8.25 ± 2.69 | 7.91 ± 2.69 |
TC (mmol/L) | 4.99 ± 1.02 | 5.27 ± 1.07 |
TG (mmol/L) | 1.55 (1.00-3.19) | 1.38 (1.00-2.42) |
LDL-C (mmol/L) | 2.96 ± 0.88 | 3.16 ± 0.96 |
HDL-C (mmol/L) | 1.23 ± 0.30 | 1.35 ± 0.34 |
Insulin (μIU/mL) | 6.9 (5.1-9.4) | 7.6 (5.6-10.2) |
HOMA-IR | 2.79 ± 1.73 | 2.94 ± 1.97 |
HbA1c (%) | 8.37 ± 2.00 | 8.32 ± 1.85 |
VAT (mm) | 48.39 ± 17.23 | 39.94 ± 16.45 |
Calf circumference (mm) | 35.96 ± 3.19 | 33.22 ± 2.64 |
Thigh circumference (mm) | 45.19 ± 4.03 | 43.88 ± 3.99 |
Mean IMT(mm) | 0.83 ± 0.19 | 0.80 ± 0.18 |
Kitt (%/min) | 2.28 ± 0.96 | 2.31 ± 0.94 |